Complete deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) results in a devastating neurological disease, the Lesch-Nyhan syndrome. This disorder has been identified as a candidate for initial attempts at somatic cell gene therapy. We have previously reported the construction of a recombinant herpes simplex virus type 1 (HSV-1) vector containing human hprt cDNA sequences under the regulatory control of the viral th~dine kinase gene (tk) [Palella et al., Mol. Cell. Biol. 8 (1988) 457-4601. Infection of HPRT-cultured rat neuronal cehs with these vectors resulted in transient expression of human hprt. In this paper, we report the expression of human hprt mRNA transcripts in the brains of mice infected in vivo with this vector by direct intracranial inoculation. Human hprt transcripts were distinguished from endogenous mouse transcripts by RNase A mapping using riboprobes transcribed from human hprt cDNA. These initial studies demonstrate the transfer and transcription of a human gene in brain cells by direct in vivo infection with recombinant HSV-1 vectors.
INTRODUCTION
The purine salvage enzyme, HPRT, catalyzes the conversion of hypoxanthine and guanine to the mononucieotides, IMP and GMP, respectively. A virtually complete deficiency of HPRT activity in humans causes the Lesch-Nyhan syndrome, a devastating disease in which overproduction of uric acid and severe neurological dysfunction occur (Seegmiller et al., 1967) . There is no effective treatAbbreviations: bp, base pair(s); HPRT, h~ox~thine-chine phosphoribosyltransferase; hpr?, gene (DNA) encoding HPRT; HSV-1, herpes simplex virus type 1; MEM, Eagle's minimum essential medium; mRNA, messenger RNA; PBS, phosphatebuffered saline; pfu, plaque-forming units; PRT, phosphoribosyltransferase; TK, thymidine kinase; r/c, gene encoding TK; wt, wild type. ment for the behavioral manifestations in this ultimately fatal disorder. Furthermore, despite the dramatic functional consequences of HPRT deficiency, no anatomical structural changes are noted in the central nervous system of these patients. For these and other reasons, attention has been focused on the Lesch-Nyhan syndrome as one of the initial candidates for therapy by somatic cell gene transfer (Anderson, 1984) .
Retroviral vectors containing human hprt gene sequences have been constructed by others (Miller et al., 1983; Changet al., 1987) . Mouse bone marrow cells infected with one of these constructs were transplanted into lethally irradiated mice. These infected bone marrow cells repopulated the hematopoietic cells of the recipient mice and transiently expressed human hprz (Miller et al., 1984) . However, previous studies have shown that restoration of HPRT activity in the circulation by either exchange transfusion or bone marrow tr~spl~tation has no demonstrable effect upon the neurological disease (Edwards et al., 1984; Nyhan et al., 1986) . Thus, it appears that the hprt gene will need to be targeted to cells of the central nervous system if somatic cell gene therapy is to be effective in treating the central nervous system manifestations of the Lesch-Nyhan syndrome.
We have previously reported construction of HSV-1 vectors (see Fig. 1 ) containing the human hprt cDNA under the regulatory control of the viral tk promoter (Palella et al., 1988) . Infection of HPRT-deficient cultured rat neuronal cells with these recombinant HSV-1 vectors resulted in transient expression of human hprt. We chose HSV-1 as the mediating vector for hprt gene transfer into neuronal cells because it is a neurotropic virus capable of establishing latent infection in neuronal cells (Baringer and Sworeland, 1973; Cook et al., 1974; Cook and Stevens, 1976) . Additionally, HSV-1 can express mammalian genes inserted into its genome in a variety of culture systems (Shih et al., 1984; Tackney et al., 1984) .
In this paper, we report expression of virally encoded human hprt mRNA in the brains of mice infected with these vectors by intracranial inoculation.
MATERIALS AND METHODS

(a) Animals
DBAl2.I mice were purchased from Charles River Laboratories. In these expe~ments, males weighing approx. 25 g were used.
(b) Materials
Enzymes for DNA modification were purchased from New England Biolabs, Beverly, MA, RNase A and RNase Tl were from Sigma Chemical Co., St. Louis, MO., RNase inhibitor (RNasin), SP6 RNA polymerase, and DNase were from Promega Biotec, Madison, WI.
[ c+~~P]GTP was obtained from New England Nuclear, Boston, MA, nitrocellulose filter from Millipore Corp., Bedford, MA, and Eagle's minimum essential medium and fetal calf serum from Gibco Laboratories, Grand Island, NY, Methoxyfluorane was purchased from Pitm~-Moore, Inc., Washington Crossing, NJ, and staphycoccal protein A (Igsorb) from the Enzyme Center, Malden, MA. All other reagents were of the highest grade commercially available. (Hidaka et al., 1987) . GM558, 904 and 905 were m~t~ned in RPM1 1640 supplemented with 10% fetal calf serum. VERO cells, used to produce stocks of viral vectors, were maintained in MEM containing Hank's salts and supplemented with 5 % fetal calf serum.
(d) Vectors
Construction and characterization of the vector, HSV-HP40, which contains the human hprt cDNA within the viral tk gene has been described previously (Palella et al., 1988) and is summarized in Fig. 1 (Palella et al., 1988) . HSV-HP40 has hprt cDNA in the correct orientation with respect to the tk promoter. Drawings are not to scale. Abbreviations: B, BarnHI; G, BglII; H, HindI; P, PstI.
(e) Infection of animals
Mice were anesthetized by methoxytluorane inhalation. Ten to 20 ~1 of viral suspension (lo7 to 2 x lo7 pfu) were injected into each cerebral hemisphere by intracranial inoculation using a Hamilton syringe. The point of injection was chosen to introduce the viral suspensions into the area of the lateral ventricles slightly anterior to the mid-coronal plane. The exact position for injection to achieve inoculation into the ventricles was empirically determined in advance by the injection of dye.
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Immediately after injection, animals were returned to their cages and allowed to feed and drink ad libitum. Mice were observed daily for illness or death. On days 2,3,5 and 7 after infection, mice were killed by cervical dislocation. The brains and livers were rapidly dissected and immediately frozen in liquid nitrogen. These organs were minced and the minced tissue was divided into halves for each animal. Half of the tissue from each brain and liver was processed for RNA extraction and the other half for protein extracts for enzymatic assays.
(f) RNase mapping
The dissected mouse brains and livers were homogenized in 6 M guanidium isothiocyanate/5 mM sodium citrate pH 7.0/0.5 M sodium sarkosyl/O. 1 M /?-mercaptoethanol using a Dounce homogenizer. Cytoplasmic RNA was then extracted from the homogenates as previously described (Chirgwin et al., 1979) .
Two different 32P-labeled antisense RNA probes were synthesized from the SP64 plasmids containing normal human hprt cDNA fragments as templates (see Fig. 2 ). Transcription was performed according to the manufacturer's recommendations, except 3 mCi/ml of [u-~*P]GTP (800 Ci/mmol) was used in the reaction mixture in place of [ c+~~P]CTP. The RNA probe, pHP64-5' was transcribed from the Hind111 site to the 5' PstI site of human hprt cDNA. This probe spans 592 bp containing 104 bp of 5'untranslated sequence and 488 bp of coding sequence. The antisense RNA probe pHP64-3' was transcribed from the 3' PstI site to the HincII site. This probe is 521 bp and contains 193 bp of 3'-untranslated sequence and 328 bp of coding sequence (see Fig. 2 ). The labeled RNA probe (lo6 cpm) was hybridized to 50 pg of cytoplasmic RNA in 30 ~1 of 80% formamide/ mM piperazine-N-Nl-bis(2-ethane sulfonic acid) (PIPES) pH 6.4/0.4 M NaCl/l mM EDTA at 50°C for 15 h. The RNA was digested at 30°C for 1 h by 40 pg/ml of RNase A and 2 pg/ml of RNase Tl in 300 ~1 of 10 mM Tris -HCl pH 7.5/5 mM EDTA/300 mM NaCl. After two ethanol precipitations, the RNase-digested RNA was electrophoresed in an 8 M urea denaturing 5% polyacrylamide gel and autoradiographed (Gibbs and Caskey, 1987) .
RESULTS AND DISCUSSION
(a) Infection with HSV-HP40
All mice infected with wt HSV-KOS became ill and died within three days regardless of the infecting dose, including the lowest dose of 2 x lo4 pfu per animal. Mice infected with the vector HSV-HP40 showed dose-dependent morbidity and mortality. Mice infected with 2-4 x 10' pfu of HSV-HP40 were ill by day 3 and 8 1 y0 (43153) were dead by day 4. At 2 x lo6 pfu of HSV-HP40, 16% (l/6) were dead by day 4. At 2 x IO5 pfu and 2 x lo4 pfu, all animals appeared healthy, and none of them died. All but two of these animals were killed by day 7. These two remained healthy until day 21 when they were killed. RNase mapping analysis was performed on four uninfected and 22 infected mice.
(b) Expression of HPRT mRNA-infected mice
RNase A mapping analysis using two overlapping human HPRT RNA probes clearly dis~n~ishes human transcripts from endogenous mouse transcripts (Figs. 2-4) . Two probes were used because the considerable degree of homology between the mouse and human HPRT-coding sequences results in complex RNase maps that are diicult to interpret. Mouse and human hprt cDNA sequences are less homologous within the 3'-and 5'untranslated regions, allowing dissemination between the species-specific mRNAs using smaller probes. The two probes used overlap in the coding region such Lanes: 1, RNA from an uninfected mouse; 2, RNA from a mouse infected with HSV-KOS (2 x 10' pfu) killed two days postinfection; 3, RNA from a mouse infected with HSV-HP40 (4 x 10' pfu) two days post-infection; 4, RNA from a mouse infected with HSV-HP40 (2 x lo7 pfu) killed two days postinfection; 5, RNA from a mouse infected with HSV-HP40 (4 x 10' pfu) killed three days ~st-i~ection; 6, RNA from a mouse infected with HSV-HP40 (4 x 10' pfu) killed two days post-infection; 7, RNA from a mouse infected with HSV-HP40 (2 x lo7 pfu) killed two days post-infection; 8, RNA from an uninfected mouse; 9, RNA from a mouse infected with HSV-HP40 (2 x IO' pfu) killed three days post-infection; 10, RNA from the lymphoblast cell tine, 904, which has normal HPRT activity; 11, RNA from lymphoblast cell line 905 which has normal HPRT activity; 12, undigested probe. The open arrowhead indicates the undigested full-length RNA probe (521 bp). The closed arrowhead represents the RNA probe protected by the normal human HPRT mRNA. The heavy black dots denote RNA probe protected by homologous regions of mouse HPRT mRNA.
that full RNase protection of both probes indicates transcription of the entire human cDNA. The riboprobe pHP64-3' protects a 521-bp fragment of HPRT mRNA from human lymphoblast lines 904 and 905 (Fig. 3, lanes 10 and 11) . (The doublet signal Fig. 4 . RNase mapping analysis of RNA from the brains and livers using the RNA probe pHP64-5' in a separate experiment from that shown in Fig. 2 . Experimental details are provided in MATERIALS AND METHODS, section f. RNA from mouse livers are in lanes 1-6. RNA from mouse brains are in lanes 8-13. Lanes: 1-3, mRNA from livers of uninfected mice; 4, mRNA from liver of mouse infected with HSV-KOS (2 x IO' pfu) and killed two days post-infection; 5, mRNA from liver of mouse infected with HSV-HP40 (4 x 10' pfu), killed two days postinfection; 6, mRNA from liver ofmouse infected with HSV-HP40 (2 x 10' pfu), killed two days post-infection; 7 and 14, mRNA from human lymphoblast line 904; S-10, mRNA from uninfected mouse brains; 11, mRNA from brain of mouse infected with HSV-KOS (2 x 10' pfu), killed two days post-i~ection; 12, mRNA from brain of mouse infected with HSV-HP40 (4 x 10' pfu), killed two days post-infection; 13, mRNA from brain of mouse infected with HSV-HP40 (2 x 10' pfu), killed two days post-infection; 15, undigested probe pHP64-5'. The open arrowhead indicates the undigested full-length RNA probe. The closed arrowhead indicates the RNA probe fully protected by the normal human HPRT mRNA (approx. 592 bp). The dots indicate mouse HPRT-specific bands. seen in these lanes is an artifact resulting from the probe construction. The hprt cDNA used to construct the RNA probes pHP64-3' and pHP64-5' as well as HSV-HP40 was cloned by poly(dG) tailing. Thus, the antisense probe pHP64-3' has a polyfdG) tail which is somewhat resistant to RNase A and Tl digestion. This results in two 'fully protected' bands when HPRT mRNA from control cells (lymphoblasts) is hybridized to this probe. The larger M, band is the incompletely digested poly(dG)-tailed hybrid. Since HSV-HP40 also contains these tails, the virally encoded message is completely complementary to the probe. Thus, hybrids of viral encoded HPRT mRNA and pHP64-3' are a single band of the higher M,.) The 521-bp band is not present in mRNA from uninfected mouse brain, although two prominent mouse-specific bands and multiple nonspecific bands are present (Fig. 3, lanes 1 and 8) . Thus, the appearance of the 521-bp band corresponds to expression of human HPRT mRNA. This band is absent in mRNA from mouse brain infected with the wt virus, HSV-KOS (lane 2) but is present in mouse brain mRNA from animals infected with HSV-HP40 (lanes 3-7 and 9). The uniform intensity of mouse-specilic bands in uninfected mRNA samples as welI as samples from mice infected with either HSV-KOS or HSV-HP40 indicates equivalence of the amount of mRNA in each assay as well as the absence of any negative impact of HSV infection on endogenous mouse brain mRNA levels. It is also apparent that human HPRT mRNA is expressed in a manner dependent upon the infecting dose of virus and duration of infection, Similar results were obtained using the RNA probe pHP64-5' with mRNA extracted from mouse brain (Fig. 4, lanes 8-13) . However, no human HPRT mRNA was detected in mRNA extracted from the livers of mice infected with HSV-HP40 that had human HPRT transcripts in brain samples (compare lanes 5 to 12, and 6 to 13 in Fig. 4 ). These data, taken together, indicate that the entire hprr cDNA contained within HSV-HP40 was transcribed in the brains, but not in the livers, of mice infected with this vector.
Infecting doses of 2-4 x lo7 pfu of HSV-HP40 resulted in considerable mortality among infected animals, although fewer animals infected with HSV-HP40 died than did those infected with HSV-KOS at comparable doses. Survival was better at lower viral doses. To assess human hprt cDNA transcription in mice with non-lethal HSV infection, mice were infected with lower doses of HSV-KOS and HSV-HP40 (Fig. 5) . No expression was detected at Fig. 5 . RNase mapping analysis of RNA from mouse brains using the antisense probe pHP64-3'. Experimental details are provided in MATERIALS AND METHODS, section f. Lanes: 1, RNA from an uninfected mouse; 2, RNA from a sham-infected (PBS) mouse; 3, RNA from a mouse infected with 2 x lo6 pfu of HSV-KOS, killed at day 3; 4, RNA from a mouse infected with 2 x IO6 pfu HSV-HP40, killed on day 3; 5, RNA from a mouse infected with 2 x 10" pm HSV-KOS, killed at day 5; 6, RNA from a mouse infected with 2 x 104 HSV-HP40 killed at day 3; 7, RNA from a mouse infected with 2 x lo5 pfu HSV-KOS killed at day 3; 8, RNA from a mouse infected with 2 x 10' pfu HSV-HP40, killed at day 5; 9, RNA from a mouse infected with 2 x lo5 HSV-HP40, killed at day 7. days 3 and 5 after infection with HSV-HP40 at a dose of 2 x lo4 pfu (lanes 5 and 6). At an infecting dose of 2 x 105, human HPRT transcripts were detected in brain mRNA five days after infection, but not at three or seven days (lanes 7-9). Human HPRT mRNA was also detected in mouse brain mRNA three days after infection with 2 x lo6 HSV-HP40, which was the only time point examined at this dose. No human HPRT transcripts were detected in uninfected, sham (PBS) infected or HSV-KOS-infected mouse brain (lanes 1,2,3,5 and 7).
(c) HPRT activity in infected mice HPRT activity, determined by radiometric assay of dialyzed brain and liver extracts, was virtually identical in all animals. Thus, there was no demonstrable difference in total enzyme activity among uninfected, HSV-KOS infected and HSV-HP40 infected mouse brains.
In an attempt to distinguish mouse from human HPRT activity in these extracts, immunoprecipitation employing anti-human HPRT antiserum was performed. The results were again equivocal (Table I) . Although a slightly higher percentage of HPRT activity was precipitated from extracts of infected brain, the absolute amount of HPRT activity precipitated as measured by the radiometric assay (i.e., as cpm) was nearly identical in all samples. Thus, these data cannot be interpreted as demonstrating the expression of human HPRT protein or activity.
Immunoblot analysis yielded similar results for two reasons. First, in native PAGE, human and mouse HPRT show identical migration under the conditions employed. Secondly, on immunoblots, anti-human HPRT antiserum cross-reacted with mouse HPRT even at antiserum dilutions of 1: 5000 (data not shown). Thus, this technique could not discriminate human from mouse HPRT.
These results demonstrate the transfer and expression of human gene sequences in mouse brain after in vivo infection with recombinant HSV-1 derived vectors. Human HPRT mRNA transcripts were detected at levels comparable to or in excess of endogenous mouse HPRT mRNA in brains infected with HSV-HP40. Expression of human HPRT mRNA was detected dependent on the infecting dose of ' Mouse brains were homogenized in 10 mM Tris + HCI pH 7.4
by a Dounce homogenizer. After centrifirgation of the homogenates to remove membranes and nuclei, the supernates were recovered for analysis. Anti-human HPRT antiserum (Wilson et al., 1981) was diluted 1: 20 in 50 mM Tris HCl pH 7.4, and 0.5 mg/ml of BSA fraction V. Antiserum (5 ~1) was added to 45 ~1 of mouse brain or liver extract adjusted to 30 pg of total protein (final ~t~seNrn dilution was i/zoo). Previous studies demonstrated that at this dilution, less than 10% of the HPRT activity in mouse brain extracts was precipitated while 90% of human HPRT activity was precipitated from extracts of GM558 cells (data not shown). Identical reactions were prepared with 5 ~1 of antiserum dilution buffer only. Samples were incubated at 37°C for 30 min and rotated overnight at 4°C. After overnight incubation, 5 +d of 10% staphylococcal protein A (Igsorb) were added to each sample which were incubated at 22°C for 10 min, after which they were centrifuged at 4000 x g for 5 min. Each supernatant (5OpI) was assayed for HPRT activity by the method of Holden and Kelley (1978) . Extracts of uninfected and infected rat brains were electrophoresed through 10% polyacrylamide gels under nondenaturing conditions. After electrophoresis, proteins were electroblotted onto nitrocellulose filters. Filters were incubated in 1% nonfat milk, 10 mM Tris HCl pH 7.4/150 mM NaCl and then with rabbit anti-human HPRT antiserum and probed with staphyioc~cus ['251]protein A (Wilson et al., 1981; . Blots were then washed, dried and exposed overnight to Kodak XAR-5 film at -70°C.
virus and duration of infection. Furthermore, there was no suppression of endogenous mouse HPRT mRNA or HPRT activity levels after infection with either HSV-KOS or HSV-HP40. Mortality also varied with infecting dose. Infection with wt virus, HSV-KOS, was nearly uniformly lethal. Survival was better in animals infected with HSV-HP40, particularly at lower infecting doses.
Expression of human HPRT mRNA was detected in these infected animals. The course of expression likely parallels viral replication in the brain. Additionally, infection -or at least expressionappeared limited to brain: no human HPRT transcripts were detected in mRNA extracted from livers of infected animals.
Human HPRT protein or enzyme activity could not be unequivocally demonstrated. There are two potential explanations for this. First, the techniques employed did not adequately discriminate mouse from human protein. Specifically, human HPRT could not be differentially immunoprecipitated in the presence of endogenous mouse HPRT. Indeed, this might reflect the fo~ation of ham-mouse HPRT heterotetramers in vivo in cells in which both mouse and human HPRT monomers were simultaneously synthesized. Such heteromer formation has been previously inferred from data obtained from transgenie mice expressing the human hprt gene (Stout et al., 1985) . Addition~ly, the sensitivity of the ~munoprecipitation assay could not be detents and, thus, the detection of a small amount of immunoprecipitable human HPRT against a mouse background might be beyond the limits of this technique. Immunoblot analysis was similarly confounded. Mouse HPRT migrates identically with human HPRT on polyacrylamide gel electrophoresis. Fu~h~ore, there was subst~ti~ cross reactivity of antiserum directed against the human protein with the murine protein.
Second, translation of the virally encoded human HPRT mRNA might be less efficient than that of endogenous mRNA. By contrast, in our previous report of expression of human HPRT in cultured rat neuronal cells, we were able to demonstrate expression of active human HPRT (Palella et al., 1988) . Expression of protein in vitro but not in vivp has been noted previously in human gene transfer experiments into animal cells using retroviral vectors (Wilson et al., 1988) . The basis for this observation is not clear, but may reflect abnormalities in mRNA structure, processing or transport.
These experiments demonstrate the transfer and expression of human gene sequences in brain after in vivo infection with recombinant HSV-1 vectors. They also serve to highlight several potential problems that await resolution in these systems.
